| The microbiome of catheter collected urine in males with bladder cancer according to disease stage B Oresta, D Braga, M Lazzeri, N Frego, A Saita, C Faccani, V Fasulo, ... The Journal of Urology 205 (1), 86-93, 2021 | 61 | 2021 |
| Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer CM de la Calle, V Fasulo, JE Cowan, PE Lonergan, M Maggi, ... The Journal of Urology 205 (2), 452-460, 2021 | 41 | 2021 |
| The long-term risks of metastases in men on active surveillance for early stage prostate cancer M Maggi, JE Cowan, V Fasulo, SL Washington III, PE Lonergan, A Sciarra, ... The Journal of urology 204 (6), 1222-1228, 2020 | 40 | 2020 |
| Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer … R Hurle, P Casale, A Saita, P Colombo, GM Elefante, G Lughezzani, ... World Journal of Urology 38, 2215-2220, 2020 | 27 | 2020 |
| Assessing the feasibility and accuracy of high-resolution microultrasound imaging for bladder cancer detection and staging A Saita, G Lughezzani, NM Buffi, R Hurle, L Nava, P Colombo, P Diana, ... European Urology 77 (6), 727-732, 2020 | 26 | 2020 |
| Long-term follow-up and factors associated with active surveillance failure for patients with non–muscle-invasive bladder cancer: the Bladder Cancer Italian Active Surveillance … R Contieri, M Paciotti, G Lughezzani, NM Buffi, N Frego, P Diana, ... European Urology Oncology 5 (2), 251-255, 2022 | 20 | 2022 |
| Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study V Fasulo, NM Buffi, F Regis, M Paciotti, F Persico, D Maffei, A Uleri, ... World Journal of Urology, 1-8, 2022 | 20 | 2022 |
| Diagnostic accuracy and prognostic value of serial prostate multiparametric magnetic resonance imaging in men on active surveillance for prostate cancer CE Chu, JE Cowan, PE Lonergan, SL Washington III, V Fasulo, ... European Urology Oncology 5 (5), 537-543, 2022 | 18 | 2022 |
| Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non–muscle-invasive bladder cancer after BCG … R Hurle, R Contieri, P Casale, E Morenghi, A Saita, N Buffi, G Lughezzani, ... Urologic Oncology: Seminars and Original Investigations 39 (3), 195. e7-195. e13, 2021 | 18 | 2021 |
| Long-term follow-up after en bloc transurethral resection of non–muscle-invasive bladder cancer: Results from a single-center experience M Paciotti, P Casale, P Colombo, V Fasulo, A Saita, G Lughezzani, ... European Urology Open Science 26, 64-71, 2021 | 16 | 2021 |
| Gender-specific risk factors for renal cell carcinoma: a systematic review G Lughezzani, M Paciotti, V Fasulo, P Casale, A Saita Current Opinion in Urology 29 (3), 272-278, 2019 | 15 | 2019 |
| Xpert bladder cancer monitor may avoid cystoscopies in patients under “active surveillance” for recurrent bladder cancer (BIAS project): longitudinal cohort study V Fasulo, M Paciotti, M Lazzeri, R Contieri, P Casale, A Saita, ... Frontiers in Oncology 12, 832835, 2022 | 13 | 2022 |
| Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional … M Lazzeri, S Duga, E Azzolini, V Fasulo, N Buffi, A Saita, G Lughezzani, ... Minerva Urology and Nephrology 74 (1), 77-84, 2021 | 13 | 2021 |
| Impact of anti-androgenic therapies on COVID-19: an observational study in male population from a COVID-19 regional centre of Lombardy (Italy) M Lazzeri, E Azzolini, NM Buffi, V Fasulo, F Persico, A Saita, R Hurle, ... MedRxiv, 2020 | 13 | 2020 |
| A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from … M Maggi, S Salciccia, F Del Giudice, GM Busetto, UG Falagario, G Carrieri, ... Frontiers in oncology 11, 700258, 2021 | 12 | 2021 |
| The role of miRNA in the management of localized and advanced renal masses, a narrative review of the literature L Napolitano, L Orecchia, C Giulioni, U Carbonara, G Tavella, L Lizzio, ... Applied Sciences 13 (1), 275, 2022 | 7 | 2022 |
| Assessing the role of high-resolution microultrasound among naïve patients with negative multiparametric magnetic resonance imaging and a persistently high suspicion of … PP Avolio, G Lughezzani, V Fasulo, D Maffei, R Sanchez-Salas, M Paciotti, ... European Urology Open Science 47, 73-79, 2023 | 6 | 2023 |
| Could we safely avoid a second resection in selected patients with T1 non-muscle-invasive bladder cancer? Preliminary results of cost-effectiveness study from humanitas new … R Contieri, G Lughezzani, NM Buffi, G Taverna, A Giacobbe, E Micheli, ... Frontiers in Oncology 12, 879399, 2022 | 6 | 2022 |
| Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic? M Paciotti, R Contieri, V Fasulo, P Casale, A Saita, NM Buffi, ... Minerva urology and nephrology 74 (1), 1-4, 2022 | 6 | 2022 |
| Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis C Saitta, JA Afari, R Autorino, U Capitanio, F Porpiglia, D Amparore, ... Urologic Oncology: Seminars and Original Investigations 41 (12), 487. e15 …, 2023 | 5 | 2023 |
Giovanni LughezzaniDeparment of Urology, Humanitas Research Hospital在 humanitas.it 的电子邮件经过验证
